{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:18:26Z","timestamp":1761175106106,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijid.2021.02.024","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T02:01:00Z","timestamp":1612922460000},"page":"632-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys\u00ae anti-SARS-CoV-2 immunoassay"],"prefix":"10.1016","volume":"105","author":[{"given":"Maximilian","family":"Kittel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Findeisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Christina","family":"Muth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Thiaucourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Gerhards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Haselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.ijid.2021.02.024_bib0005","doi-asserted-by":"crossref","first-page":"eabc6347","DOI":"10.1126\/sciimmunol.abc6347","article-title":"Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward","volume":"5","author":"Bryant","year":"2020","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.024_bib0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ajcp\/aqaa155","article-title":"Analytical and clinical evaluation of the automated Elecsys anti-SARS-CoV-2 antibody assay on the Roche cobas e602 analyzer","volume":"154","author":"Chan","year":"2020","journal-title":"Am J Clin Pathol"},{"year":"2012","series-title":"Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline\u2014second edition. EP17-A2","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.ijid.2021.02.024_bib0015"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.024_bib0020","first-page":"CD013652","article-title":"Antibody tests for identification of current and past infection with SARS-CoV-2","author":"Deeks","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ijid.2021.02.024_bib0025","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/cid\/ciaa742","article-title":"The laboratory diagnosis of coronavirus disease 2019\u2014frequently asked questions","volume":"71","author":"Fang","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.ijid.2021.02.024_bib0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.02.024_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2020.07.007","article-title":"Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples","volume":"510","author":"Haselmann","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.024_bib0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bj.2020.05.018","article-title":"Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan","volume":"43","author":"Huang","year":"2020","journal-title":"Biomed J"},{"key":"10.1016\/j.ijid.2021.02.024_bib0045","article-title":"Comparison of two automated immunoassays for the detection of SARS-CoV-2 nucleocapsid antibodies","author":"Hubbard","year":"2020","journal-title":"J Appl Lab Med"},{"year":"2020","series-title":"Serology-based tests for COVID-19","author":"Johns Hopkins Center for Health Security","key":"10.1016\/j.ijid.2021.02.024_bib0050"},{"year":"2020","series-title":"CSSEGISandData\/COVID-19","author":"Johns Hopkins Whiting School of Engineering","key":"10.1016\/j.ijid.2021.02.024_bib0055"},{"issue":"13","key":"10.1016\/j.ijid.2021.02.024_bib0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.15585\/mmwr.mm6913e1","article-title":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility \u2013 King County, Washington, March 2020","volume":"69","author":"Kimball","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.024_bib0065","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/jmv.26145","article-title":"Clinical performance of different SARS-CoV-2 IgG antibody tests","volume":"92","author":"Kohmer","year":"2020","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.024_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/diagnostics10050319","article-title":"Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis","volume":"10","author":"Kontou","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.024_bib0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/M20-1495","article-title":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure","volume":"173","author":"Kucirka","year":"2020","journal-title":"Ann Int Med"},{"issue":"7821","key":"10.1016\/j.ijid.2021.02.024_bib0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41586-020-2488-1","article-title":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019","volume":"584","author":"Lavezzo","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.024_bib0085","doi-asserted-by":"crossref","first-page":"2000180","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","article-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020","volume":"25","author":"Mizumoto","year":"2020","journal-title":"Euro Surveill"},{"year":"2020","series-title":"IMMUNITOR Rechner","author":"Neumaier","key":"10.1016\/j.ijid.2021.02.024_bib0090"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.024_bib0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review","volume":"173","author":"Oran","year":"2020","journal-title":"Ann Int Med"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.024_bib0100","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/jmv.25988","article-title":"Comparison of SARS\u2010CoV\u20102 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS\u2010CoV\u20102 test and a laboratory\u2010developed real\u2010time RT\u2010PCR test","volume":"92","author":"Pujadas","year":"2020","journal-title":"J Med Virol"},{"year":"2020","series-title":"Elecsys\u00ae Anti-SARS-CoV-2","author":"Roche Diagnostics","key":"10.1016\/j.ijid.2021.02.024_bib0105"},{"issue":"22","key":"10.1016\/j.ijid.2021.02.024_bib0110","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMc2009316","article-title":"Universal screening for SARS-CoV-2 in women admitted for delivery","volume":"382","author":"Sutton","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.024_bib0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5858\/arpa.2020-0499-SA","article-title":"Comparative clinical evaluation of the Roche Elecsys and Abbott SARS-CoV-2 serology assays for COVID-19","volume":"145","author":"Tan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ijid.2021.02.024_bib0120","doi-asserted-by":"crossref","first-page":"104613","DOI":"10.1016\/j.jcv.2020.104613","article-title":"Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody","volume":"132","author":"Trabaud","year":"2020","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.024_bib0125","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2016321","article-title":"Swabs collected by patients or health care workers for SARS-CoV-2 testing","volume":"383","author":"Tu","year":"2020","journal-title":"N Engl J Med"},{"year":"2020","series-title":"Policy for coronavirus disease-2019 tests during the public health emergency (revised)","author":"U.S. Food & Drug Administration","key":"10.1016\/j.ijid.2021.02.024_bib0130"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.024_bib0135","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cmi.2020.05.023","article-title":"Diagnostic performance of 7 rapid IgG\/IgM antibody tests and the Euroimmun IgA\/IgG ELISA in COVID-19 patients","volume":"26","author":"Van Elslande","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.024_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.medcli.2020.07.008","article-title":"Cross-reactions between rheumatoid factor and IgM SARS-CoV-2","volume":"155","author":"Viny\u00e9 Baus\u00e0","year":"2020","journal-title":"Med Clin"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.024_bib0145","doi-asserted-by":"crossref","first-page":"e00375","DOI":"10.1128\/JCM.00375-20","article-title":"A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays","volume":"58","author":"Wang","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"18","key":"10.1016\/j.ijid.2021.02.024_bib0150","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.024_bib0155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1473-3099(20)30322-4","article-title":"The important role of serology for COVID-19 control","volume":"20","author":"Winter","year":"2020","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:54Z","timestamp":1761120294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"alternative-id":["S1201971221001107"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.024","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys\u00ae anti-SARS-CoV-2 immunoassay","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}